Mentor Graphics (NASDAQ:MENT) is steady after hours Thursday after it edges out the Street view with Q4 earnings and provides mixed guidance. The company reports non-GAAP income of $107 million or $0.92 per share compared to $67 million or $0.58 per share a year earlier. The company reports Q4 revenues of $401 million, up from…
Aegerion Pharmaceuticals (NASDAQ:AEGR) is lower after it reported a Q4 loss that was smaller than analysts had expected and set a FY14 sales guidance that straddled estimates. Shares are down 11.48% at $58.73 with a 52-week range of $28.33 – $101.00. In the quarter, the biopharmaceutical company had a non-GAAP loss of $0.14 per share,…
LinkedIn (NYSE:LNKD) is higher this morning after RBC upgraded the shares to Outperform from Sector Perform and set a price target of $250 per share, up from $225 per share. JPMorgan analysts have downgraded their coverage of industrial manufacturer Dynamic Materials Corporation (NASDAQ:BOOM) to a Neutral rating from Overweight. The firm also lowered its price…
Shares of Anika Therapeutics, Inc. (NASDAQ:ANIK) are up 17.3%, positioning for a new 52-week high of $40.99 if the gains should hold into Wednesday. The stock just came off an evening-session halt after the company said it received FDA marketing approval for MONOVISC, a single injection supplement to synovial fluid of the osteoarthritic joint, used…
Shares of Orexigen Therapeutics (NASDAQ:OREX) slipped in Tuesday’s pre-market session, after the developer of drug treatments for obesity and related disorders said it received a Day 120 List of Questions regarding the marketing authorization application for its NB32 weight-loss drug candidate from the European Medicines Agency’s Committee for Medicinal Products for Human Use. The company…
CoreLogic (NYSE: CLGX) announced that intends to divest its Asset Management and Processing Solutions segment, the area of its business that offers services to banks that allow them to handle their portfolio of foreclosed properties. The segment will now be classified as held for sale, and the company will take a noncash impairment charge of…
